Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine
- 1 May 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 43 (5) , 366-369
- https://doi.org/10.1111/j.2042-7158.1991.tb06707.x
Abstract
The protective action of meptazinol against acute diisopropyl fluorophosphate (DFP) intoxication has been evaluated in mice by measuring the effects on the DFP LD50 of the pretreatment of the animals with increasing doses of the drug. Meptazinol at the doses 15, 30 and 45 mg kg−1 injected 15 min before DFP caused a dose-dependent increase in the DFP LD50, resulting in protection ratios equal to 2.1, 4.8 and 9.7, respectively, in the absence of atropine and 2.5, 4.7 and 8, respectively, in the presence of atropine sulphate (17.4 mg kg−1) therapy. Under the same experimental conditions, the protective ratio of 0.1 mg kg−1 physostigmine sulphate was 2.2 and 7.3 in the absence and presence of atropine therapy, respectively. In separate experiments, the time course of acetylcholinesterase (AChE) activity recovery was evaluated in the brain and diaphragm of mice pretreated with meptazinol (30 mg kg−1) or physostigmine (0.1 mg kg−1) 15 min before poisoning with DFP (8 mg kg−1). Ten minutes after poisoning, residual AChE activity in the brain averaged 4, 47 and 15% of that in controls in animals pretreated with atropine alone, atropine plus meptazinol or atropine plus physostigmine, respectively. Twenty four hours after poisoning, brain AChE activity averaged 31 and 47% of that in controls in mice protected by meptazinol and physostigmine, respectively. The data from the diaphragm closely paralleled those from the brain. It is concluded that high doses of meptazinol exert antidotal action against acute DFP poisoning in the mouse comparable in efficacy with that of physostigmine combined with atropine. This action is most probably due to the ability of meptazinol to protect AChE from irreversible inactivation by DFP.Keywords
This publication has 18 references indexed in Scilit:
- Protection against diisopropylfluorophosphate intoxication by meptazinolToxicology and Applied Pharmacology, 1988
- Prevention of physostigmine‐induced lethality by the opioid analgesic meptazinol in the mouseBritish Journal of Pharmacology, 1987
- Meptazinol A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic EfficacyDrugs, 1985
- Inhibition of cholinesterases by the opioid analgesic meptazinolBiochemical Pharmacology, 1985
- In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamatesJournal of Pharmacy and Pharmacology, 1985
- Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- A theoretical kinetic analysis of the protective action exerted by eserine and other carbamate anticholinesterases against poisoning by organophosphorus compoundsBiochemical Pharmacology, 1983
- Effects of 1,1′-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximesBiochemical Pharmacology, 1978
- The protection of animals against organophosphate poisoning by pretreatment with a carbamateToxicology and Applied Pharmacology, 1978
- The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridateBiochemical Pharmacology, 1970